Oleoylethanolamide (OEA) 98%+ – Powder, 5 grams
$34.99
Oleoylethanolamide (OEA) is an ethanolamide lipid derived from oleic acid, classified within the N-acylethanolamine family of bioactive lipid signalling molecules. Research interest centers on its function as an endogenous agonist of peroxisome proliferator-activated receptor alpha (PPAR-alpha), a nuclear receptor… CAS: 111-58-0 | Formula: C20H39NO2 | Content: 5 grams | Research use only | Third-party lab tested.
Buy Oleoylethanolamide (OEA) 98%+ – Powder, 5 grams – Swiss Chems USA
Oleoylethanolamide (OEA) 98%+ – Powder, 5 grams — Research Overview
Oleoylethanolamide (OEA) is an ethanolamide lipid derived from oleic acid, classified within the N-acylethanolamine family of bioactive lipid signalling molecules. Research interest centers on its function as an endogenous agonist of peroxisome proliferator-activated receptor alpha (PPAR-alpha), a nuclear receptor governing lipid metabolism gene transcription. Research applications include PPAR-alpha pathway studies, lipid signalling research, and N-acylethanolamine biosynthesis/degradation pathway investigation.
- High Purity – 99% Purity Guaranteed
- Independently Lab Tested
- Research Grade Quality
- For Laboratory Research Use Only
Intended use: This material is supplied for laboratory and in-vitro research only. It is not a drug, food, or cosmetic and is not intended for human or animal consumption.
Oleoylethanolamide (OEA) 98%+ – Powder, 5 grams Chemical Properties
| Property | Specification |
|---|---|
| Chemical Formula | C20H39NO2 |
| Synonyms | n-oleoylethanolamine, oleoylethanolamide, N-(2-Hydroxyethyl)oleamide, Oleylethanolamide, Oleamide MEA, N-oleoyl ethanolamine |
| Molar Mass | 325.5 g/mol |
| CAS Number | 111-58-0 |
| PubChem CID | 5283454 |
| Total Compound Content | 5 grams |
| Shelf Life | 36 months |
Oleoylethanolamide (OEA) 98%+ – Powder, 5 grams Research Applications
OEA is synthesized in vivo via hydrolysis of the membrane phospholipid precursor N-acylphosphatidylethanolamine, and is degraded primarily through fatty acid amide hydrolase (FAAH) enzymatic activity — the same enzyme responsible for degrading the endocannabinoid anandamide, positioning OEA within overlapping N-acylethanolamine metabolic pathway research. As an endogenous PPAR-alpha agonist, OEA is studied for its capacity to activate this nuclear receptor’s transcriptional program governing fatty acid oxidation and lipid metabolism gene expression, distinguishing it from cannabinoid receptor-acting N-acylethanolamines. Cell-based PPAR-alpha reporter assays and enzymatic FAAH activity assays are standard methods for characterising OEA’s signalling and metabolic pathway interactions. Independently third-party HPLC-tested; COA available per batch.
Oleoylethanolamide (OEA) 98%+ – Powder, 5 grams Frequently Asked Questions
What is the mechanistic basis for OEA’s classification as a PPAR-alpha agonist?
OEA binds directly to and activates peroxisome proliferator-activated receptor alpha (PPAR-alpha), a ligand-activated nuclear transcription factor that, upon activation, heterodimerizes with retinoid X receptor (RXR) and binds PPAR-response elements in target gene promoters to upregulate fatty acid oxidation and lipid metabolism genes. Cell-based PPAR-alpha transactivation reporter assays, using a PPAR-response-element-driven luciferase construct, are the standard method for confirming and quantifying OEA’s agonist activity at this receptor relative to synthetic PPAR-alpha agonist reference compounds (such as fenofibrate).
How does OEA’s biosynthesis and degradation pathway relate to other N-acylethanolamine signaling lipids?
OEA is synthesized via hydrolysis of N-acylphosphatidylethanolamine (the same precursor class that generates other N-acylethanolamines, including the endocannabinoid anandamide) and is degraded by fatty acid amide hydrolase (FAAH), the same enzyme that degrades anandamide. This shared biosynthetic and degradative machinery means that FAAH inhibitor compounds, used in endocannabinoid research, also affect OEA levels — a consideration relevant to experimental design when FAAH inhibitors are used and PPAR-alpha-mediated effects need to be distinguished from cannabinoid-receptor-mediated effects.
What enzymatic assays are used to study FAAH-mediated degradation of OEA in research models?
Standard FAAH activity assays measure the enzymatic hydrolysis rate of OEA (or a fluorogenic/radiolabeled substrate analog) into oleic acid and ethanolamine, typically using tissue homogenates, recombinant FAAH enzyme preparations, or cell lysates. These assays allow researchers to characterise FAAH kinetic parameters (Km, Vmax) with OEA as substrate and to evaluate the potency of FAAH inhibitor compounds, which indirectly elevate OEA tissue concentration by blocking its primary degradation pathway.
Research Use Disclaimer
All product information is provided for educational and laboratory research reference only. Any form of introduction into humans or animals is prohibited. Handle only in licensed research settings in accordance with applicable laws and institutional protocols.
| Weight | 0.17 lbs |
|---|
Reviews
There are no reviews yet.